来曲唑联合利拉鲁肽治疗肥胖型多囊卵巢综合征患者的效果观察  

Observation on the efficacy of letrozole combined with liraglutide in the treatment of obese patients with polycystic ovary syndrome

作　　者：成景山 Cheng Jingshan(Department of Endocrinology,Chongzuo People's Hospital,Chongzuo 532200,China)

机构地区：[1]崇左市人民医院内分泌科,广西崇左532200

出　　处：《实用妇科内分泌电子杂志》2024年第22期37-39,共3页Electronic Journal of Practical Gynecological Endocrinology

摘　　要：目的探究来曲唑与利拉鲁肽联合应用于肥胖型多囊卵巢综合征(PCOS)患者中的效果。方法选取60例肥胖型PCOS患者,按照随机数字表法分为两组,各30例。对照组采用来曲唑治疗,试验组采用来曲唑联合利拉鲁肽治疗,比较两组临床效果。结果试验组治疗总有效率、优势卵泡数量、子宫内膜厚度及性激素水平与对照组相比均较优,差异具有统计学意义(P<0.05)。结论来曲唑与利拉鲁肽联合用于肥胖型PCOS患者的临床治疗中,能够有效针对患者疾病状况进行改善,提升临床治疗效果,值得临床应用与推广。Objective To investigate the efficacy of the combination of letrozole and liraglutide in obese patients with polycystic ovary syndrome(PCOS).Methods 60 obese PCOS patients were selected and divided into two groups(30 cases each)according to random number table method.The control group was treated with letrozole,and the experimental group was treated with letrozole combined with liraglutide.The clinical effects were compared between the two groups.Results The total effective rate,number of dominant follicles,endometrial thickness and sex hormone level of experimental group were better than those of control group,and the differences were statistically significant(P<0.05).Conclusion The combination of letrozole and liraglutide in the clinical treatment of obese PCOS patients can effectively improve the disease status of patients and enhance the clinical treatment effect,which is worthy of clinical application and promotion.

关 键 词：来曲唑 利拉鲁肽 肥胖型多囊卵巢综合征 

分 类 号：R71[医药卫生—妇产科学]